Annual change in low-prevalence (orange) and hotspot (red) implementation units (IUs). by Lydia Trippler (10136316)

Subjects:

Sphingolipid biosynthetic pathway. by Hala Tamim El Jarkass (16625309)

Subjects:

Lipidomic data from infected and uninfected adults and their embryos. by Hala Tamim El Jarkass (16625309)

Subjects:

All infection data from the study. by Hala Tamim El Jarkass (16625309)

Subjects:

Intrauterine supplementation of <i>Kif15</i> in E15 <i>Kif15</i>^<i>-/-</i> mice rescued the distribution of PSD95 in <i>Kif15</i>^<i>-/-</i> PFC neurons. by Xiaomei He (795333)

Subjects:

Characteristics of study subjects. by Jung Eun Choi (563339)

Subjects:

Changes in the white blood cell count. by Lu Yang (30847)

“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”

Detailed table of sandstones mechanical parameters change. by Wenyu Lv (20139458)

Subjects:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …”

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

Subjects:

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. by Shobnom Mustaree (21728815)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and simple steatosis (SS) groups, and adjusted p-values. by Laia Bertran (3685147)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. by Daisuke Sugahara (2047696)

Fuchioka dataset 251021. by Yusuke Fuchioka (22806178)

Subjects:

An exemplary case one year after open wedge high tibial osteotomy (OWHTO) for right knee osteoarthritis. by Yusuke Fuchioka (22806178)

Subjects:

Patellar 3D-MRI before and after OWHTO in all cases. by Yusuke Fuchioka (22806178)

Subjects:

Quantification of cartilage thickness in all cases. by Yusuke Fuchioka (22806178)

Subjects:

Detailed analysis of the patellofemoral interactions after OWHTO in Knee 01. by Yusuke Fuchioka (22806178)

Subjects: